symbol,statement_type,period_end,line_item,value
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Tax Effect Of Unusual Items,-4911972.134444
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Tax Rate For Calcs,0.258525
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Normalized EBITDA,1818690000.0
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Total Unusual Items,0.0
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Total Unusual Items Excluding Goodwill,-19000000.0
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,1032430000.0
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Reconciled Depreciation,393070000.0
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Reconciled Cost Of Revenue,6153370000.0
EXPLEOSOL.NS,income,2025-03-31 00:00:00,EBITDA,1818690000.0
EXPLEOSOL.NS,income,2025-03-31 00:00:00,EBIT,1425620000.0
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Net Interest Income,-33220000.0
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Interest Expense,33220000.0
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Interest Income,
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Normalized Income,1065518027.865556
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,1032430000.0
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Total Expenses,8965380000.0
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Rent Expense Supplemental,
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Diluted Average Shares,
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Basic Average Shares,
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Diluted EPS,
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Basic EPS,
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Diluted NI Availto Com Stockholders,1032430000.0
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Net Income Common Stockholders,1032430000.0
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Net Income,1032430000.0
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Minority Interests,0.0
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Net Income Including Noncontrolling Interests,1032430000.0
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Net Income Continuous Operations,1032430000.0
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Tax Provision,359970000.0
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Pretax Income,1392400000.0
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Other Non Operating Income Expenses,111600000.0
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Special Income Charges,-19000000.0
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Other Special Charges,
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Write Off,
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Net Non Operating Interest Income Expense,-33220000.0
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Interest Expense Non Operating,33220000.0
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Interest Income Non Operating,
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Operating Income,1282580000.0
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Operating Expense,2812010000.0
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Other Operating Expenses,2418940000.0
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Depreciation And Amortization In Income Statement,393070000.0
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Amortization,
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Depreciation Income Statement,393070000.0
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Selling General And Administration,
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Selling And Marketing Expense,
EXPLEOSOL.NS,income,2025-03-31 00:00:00,General And Administrative Expense,
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Rent And Landing Fees,
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Gross Profit,4094590000.0
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Cost Of Revenue,6153370000.0
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Total Revenue,10247960000.0
EXPLEOSOL.NS,income,2025-03-31 00:00:00,Operating Revenue,10247960000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Tax Rate For Calcs,0.243657
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Normalized EBITDA,1558490000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Total Unusual Items,0.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Total Unusual Items Excluding Goodwill,0.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,904390000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Reconciled Depreciation,336660000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Reconciled Cost Of Revenue,5798210000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,EBITDA,1558490000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,EBIT,1221830000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Net Interest Income,-26090000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Interest Expense,26090000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Interest Income,69370000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Normalized Income,904390000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,904390000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Total Expenses,8502000000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Rent Expense Supplemental,22820000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Diluted Average Shares,15520680.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Basic Average Shares,15520680.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Diluted EPS,58.27
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Basic EPS,58.27
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Diluted NI Availto Com Stockholders,904390000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Net Income Common Stockholders,904390000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Net Income,904390000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Minority Interests,0.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Net Income Including Noncontrolling Interests,904390000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Net Income Continuous Operations,904390000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Tax Provision,291350000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Pretax Income,1195740000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Other Non Operating Income Expenses,69700000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Special Income Charges,0.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Other Special Charges,1720000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Write Off,400000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Net Non Operating Interest Income Expense,-26090000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Interest Expense Non Operating,26090000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Interest Income Non Operating,69370000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Operating Income,1146700000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Operating Expense,2703790000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Other Operating Expenses,2367130000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Depreciation And Amortization In Income Statement,336660000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Amortization,101340000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Depreciation Income Statement,336660000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Selling General And Administration,1503750000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Selling And Marketing Expense,59450000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,General And Administrative Expense,1444300000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Rent And Landing Fees,22820000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Gross Profit,3850490000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Cost Of Revenue,5798210000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Total Revenue,9648700000.0
EXPLEOSOL.NS,income,2024-03-31 00:00:00,Operating Revenue,9648700000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Tax Effect Of Unusual Items,423678.871181
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Tax Rate For Calcs,0.280582
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Normalized EBITDA,2160950000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Total Unusual Items,1510000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Total Unusual Items Excluding Goodwill,1510000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,1338880000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Reconciled Depreciation,278840000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Reconciled Cost Of Revenue,4589220000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,EBITDA,2162460000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,EBIT,1883620000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Net Interest Income,17900000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Interest Expense,22560000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Interest Income,40460000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Normalized Income,1337793678.871181
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,1338880000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Total Expenses,7299690000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Rent Expense Supplemental,9350000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Diluted Average Shares,15519739.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Basic Average Shares,15519739.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Diluted EPS,86.27
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Basic EPS,86.27
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Diluted NI Availto Com Stockholders,1338880000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Net Income Common Stockholders,1338880000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Net Income,1338880000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Minority Interests,0.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Net Income Including Noncontrolling Interests,1338880000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Net Income Continuous Operations,1338880000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Tax Provision,522180000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Pretax Income,1861060000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Other Non Operating Income Expenses,1220000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Special Income Charges,1510000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Other Special Charges,-8470000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Write Off,6960000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Net Non Operating Interest Income Expense,17900000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Interest Expense Non Operating,22560000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Interest Income Non Operating,40460000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Operating Income,1733260000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Operating Expense,2710470000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Other Operating Expenses,630660000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Depreciation And Amortization In Income Statement,278840000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Amortization,
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Depreciation Income Statement,278840000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Selling General And Administration,1499170000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Selling And Marketing Expense,78290000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,General And Administrative Expense,1420880000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Rent And Landing Fees,9350000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Gross Profit,4443730000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Cost Of Revenue,4589220000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Total Revenue,9032950000.0
EXPLEOSOL.NS,income,2023-03-31 00:00:00,Operating Revenue,9032950000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Tax Effect Of Unusual Items,3383314.593986
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Tax Rate For Calcs,0.385343
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Normalized EBITDA,1292050000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Total Unusual Items,8780000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Total Unusual Items Excluding Goodwill,8780000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,676780000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Reconciled Depreciation,187640000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Reconciled Cost Of Revenue,3694370000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,EBITDA,1300830000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,EBIT,1113190000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Net Interest Income,12600000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Interest Expense,12120000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Interest Income,24720000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Normalized Income,671383314.593986
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,676780000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Total Expenses,6371220000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Rent Expense Supplemental,9110000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Diluted Average Shares,10252850.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Basic Average Shares,10252850.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Diluted EPS,66.012457
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Basic EPS,66.012457
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Diluted NI Availto Com Stockholders,676780000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Net Income Common Stockholders,676780000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Net Income,676780000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Minority Interests,0.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Net Income Including Noncontrolling Interests,676780000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Net Income Continuous Operations,676780000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Tax Provision,424290000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Pretax Income,1101070000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Other Non Operating Income Expenses,3380000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Special Income Charges,8780000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Other Special Charges,-8780000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Write Off,0.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Net Non Operating Interest Income Expense,12600000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Interest Expense Non Operating,12120000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Interest Income Non Operating,24720000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Operating Income,1054130000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Operating Expense,2676850000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Other Operating Expenses,534420000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Depreciation And Amortization In Income Statement,187640000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Amortization,
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Depreciation Income Statement,187640000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Selling General And Administration,1711500000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Selling And Marketing Expense,63910000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,General And Administrative Expense,1647590000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Rent And Landing Fees,9110000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Gross Profit,3730980000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Cost Of Revenue,3694370000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Total Revenue,7425350000.0
EXPLEOSOL.NS,income,2022-03-31 00:00:00,Operating Revenue,7425350000.0
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Tax Effect Of Unusual Items,
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Tax Rate For Calcs,
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Normalized EBITDA,
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Total Unusual Items,
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Total Unusual Items Excluding Goodwill,
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Reconciled Depreciation,
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Reconciled Cost Of Revenue,
EXPLEOSOL.NS,income,2021-03-31 00:00:00,EBITDA,
EXPLEOSOL.NS,income,2021-03-31 00:00:00,EBIT,
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Net Interest Income,
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Interest Expense,
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Interest Income,19330000.0
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Normalized Income,
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Total Expenses,
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Rent Expense Supplemental,4220000.0
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Diluted Average Shares,10252485.0
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Basic Average Shares,10252485.0
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Diluted EPS,49.2
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Basic EPS,49.2
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Diluted NI Availto Com Stockholders,
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Net Income Common Stockholders,
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Otherunder Preferred Stock Dividend,
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Net Income,
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Minority Interests,
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Net Income Including Noncontrolling Interests,
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Net Income Continuous Operations,
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Tax Provision,
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Pretax Income,
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Other Non Operating Income Expenses,
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Special Income Charges,
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Other Special Charges,-4060000.0
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Write Off,
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Net Non Operating Interest Income Expense,
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Interest Expense Non Operating,
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Interest Income Non Operating,19330000.0
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Operating Income,
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Operating Expense,
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Other Operating Expenses,
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Depreciation And Amortization In Income Statement,
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Amortization,
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Depreciation Income Statement,
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Selling General And Administration,545210000.0
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Selling And Marketing Expense,52560000.0
EXPLEOSOL.NS,income,2021-03-31 00:00:00,General And Administrative Expense,492650000.0
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Rent And Landing Fees,4220000.0
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Gross Profit,
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Cost Of Revenue,
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Total Revenue,
EXPLEOSOL.NS,income,2021-03-31 00:00:00,Operating Revenue,
